Megaphone Eyewire headlines are now available as a weekly podcast! Listen Now

Now Playing

Eyewire TV September 7, 2022 thumbnail

Introduction

story 1 thumbnail

Iveric bio Reports Topline Results of Second Phase 3 Trial of Geographic Atrophy Drug Candidate

story 2 thumbnail

Outlook Therapeutics Resubmits BLA to the FDA for Investigational Wet AMD Drug

story 3 thumbnail

Teva Receives Marketing Authorization in Europe for Lucentis Biosimilar Ranivisio


Previous EyewireTV Episodes